Company: ZVRA
Filing Date: 2025-04-07
Form Type: 8-K
Source: 0001193125-25-073991
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-07
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01      Other Events.  

As noted above, on April 7, 2025, the Company announced that as of March 31, 2025, the Company’s cash, cash equivalents and investments were approximately $68.7 million.

The foregoing cash, cash equivalents and investments information provided in this Current Report on Form8-Kis based on preliminary unaudited information and management estimates for the quarter ended March 31, 2025, is not a comprehensive statement of the Company’s financial results as of and for the fiscal quarter ended March 31, 2025 or any other period, and is subject to completion of the Company’s financial closing procedures. The Company’s independent registered public accounting firm has not conducted a review of and does not express an opinion or any other form of assurance with respect to this preliminary estimate.